Short Interest in Iradimed Corporation (NASDAQ:IRMD) Expands By 6.3%

Iradimed Corporation (NASDAQ:IRMD) was the recipient of a large increase in short interest in November. As of November 15th, there was short interest totalling 85,900 shares, an increase of 6.3% from the October 31st total of 80,800 shares. Approximately 1.1% of the company’s shares are sold short. Based on an average daily volume of 42,300 shares, the short-interest ratio is presently 2.0 days.

Insiders Place Their Bets

In related news, CFO John Glenn sold 2,500 shares of the stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $54.18, for a total value of $135,450.00. Following the sale, the chief financial officer now directly owns 4,383 shares in the company, valued at $237,470.94. This trade represents a 36.32 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 37.10% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Shaker Investments LLC OH boosted its holdings in shares of Iradimed by 1.7% in the second quarter. Shaker Investments LLC OH now owns 20,605 shares of the medical equipment provider’s stock valued at $905,000 after purchasing an additional 347 shares during the period. Jacobs Levy Equity Management Inc. grew its position in Iradimed by 1.9% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 24,779 shares of the medical equipment provider’s stock valued at $1,246,000 after acquiring an additional 472 shares in the last quarter. ClariVest Asset Management LLC raised its position in shares of Iradimed by 2.9% during the 2nd quarter. ClariVest Asset Management LLC now owns 17,666 shares of the medical equipment provider’s stock worth $776,000 after acquiring an additional 494 shares in the last quarter. Huntington National Bank raised its stake in Iradimed by 51.3% during the 3rd quarter. Huntington National Bank now owns 1,487 shares of the medical equipment provider’s stock valued at $75,000 after acquiring an additional 504 shares during the last quarter. Finally, Cim LLC increased its holdings in Iradimed by 5.9% in the second quarter. Cim LLC now owns 10,089 shares of the medical equipment provider’s stock valued at $464,000 after buying an additional 561 shares in the last quarter. Institutional investors own 92.34% of the company’s stock.

Iradimed Trading Down 0.2 %

NASDAQ IRMD opened at $53.84 on Tuesday. The firm has a market capitalization of $682.09 million, a PE ratio of 36.87 and a beta of 0.82. The business’s 50-day moving average price is $51.69 and its two-hundred day moving average price is $47.27. Iradimed has a 12 month low of $40.18 and a 12 month high of $57.95.

Iradimed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, November 25th. Investors of record on Friday, November 15th were given a dividend of $0.15 per share. The ex-dividend date of this dividend was Friday, November 15th. This represents a $0.60 annualized dividend and a yield of 1.11%. Iradimed’s payout ratio is 41.10%.

Iradimed Company Profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.